Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
| ▸ | FABP3 | P05413 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinic Acid SCHEMBL18575091 | 0.95 | CA1 (0.40) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL28785415 | 0.94 | MEN1 (0.42) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Valeric Acid SCHEMBL446966 | 0.94 | CA1 (0.47) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Hexanoate SCHEMBL19406559 | 0.93 | FABP3 (0.42) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Octanoic Acid SCHEMBL3125477 | 0.91 | FABP3 (0.44) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Propionic Acid SCHEMBL358643 | 0.91 | MEN1 (0.39) | MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1 | |
| Bicarbonate SCHEMBL5032083 | 0.91 | MEN1 (0.41) | MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1 | |
| Levulinic Acid SCHEMBL357673 | 0.90 | MEN1 (0.41) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Glycolic Acid SCHEMBL18575074 | 0.89 | MEN1 (0.38) | CA1MEN1HSP90AA1KMT2ASMN1; SMN2 | |
| Bicarbonate SCHEMBL2127090 | 0.89 | MEN1 (0.40) | MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12421350-B2 | Process of preparing a poly(anthranilide), poly(anthranilide) and its use | COVESTRO DEUTSCHLAND AG (DE) | 2025-09-23 | — | — | US | claimed |
| US-20230257523-A1 | METHOD FOR PRODUCING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND USE THEREOF | COVESTRO DEUTSCHLAND AG (DE) | 2023-08-17 | — | — | US | claimed |
| US-20230235120-A1 | PROCESS OF PREPARING A POLY(ANTHRANILIDE), POLY(ANTHRANILIDE) AND ITS USE | COVESTRO DEUTSCHLAND AG (DE) | 2023-07-27 | — | — | US | claimed |
| EP-4179004-A1 | METHOD FOR PRODUCING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND USE THEREOF | Covestro Deutschland AG (DE) | 2023-05-17 | — | — | EP | claimed |
| EP-4179005-A1 | PROCESS OF PREPARING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND ITS USE | Covestro Deutschland AG (DE) | 2023-05-17 | — | — | EP | claimed |
| CN-115996969-A | Method for producing poly (anthranilamide), poly (anthranilamide) and use thereof | 科思创德国股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115768815-A | Method for producing poly (anthranilamides), poly (anthranilamides) and use thereof | 科思创德国股份有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-109988449-A | A method of preparing titanium dioxide/cenosphere complex reflex thermal insulating filling | 中国石油化工股份有限公司 | 2019-07-09 | — | — | CN | claimed |
| CN-103193964-B | A kind of preparation method of cellulose ester grafted aliphatic polyester multipolymer | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2015-08-19 | — | — | CN | claimed |
| CN-102936762-B | Preparation method of chitosan/cellulose homogeneous spinning solution | CHINA TEXTILE ACADEMY | 2015-04-08 | — | — | CN | claimed |
| US-7919631-B2 | Production of ionic liquids | EASTMAN CHEMICAL COMPANY (US) | 2011-04-05 | — | — | US | claimed |
| EP-2121766-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-25 | — | — | EP | claimed |
| EP-2118143-A1 | REFORMATION OF IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-18 | — | — | EP | claimed |
| EP-2118070-A1 | PRODUCTION OF IONIC LIQUIDS | Eastman Chemical Company (US) | 2009-11-18 | — | — | EP | claimed |
| WO-2008100569-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| WO-2008100577-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| WO-2008100566-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | claimed |
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
| US-20080194807-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | GLUL, ICMT, ALAD | FFAR3 3797/4885HDAC3 3816/4885HDAC1 3780/4885 |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | CEL, ACMSD, ACOT7 | FFAR3 787/4885HDAC3 299/4885HDAC1 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.